Cello Group plc (CLL) Rating Reiterated by FinnCap
Cello Group plc (LON:CLL)‘s stock had its “buy” rating reaffirmed by equities researchers at FinnCap in a note issued to investors on Tuesday. They presently have a GBX 132 ($1.72) price objective on the stock. FinnCap’s price target points to a potential upside of 23.94% from the stock’s previous close.
Several other equities analysts have also commented on the stock. N+1 Singer reaffirmed a “buy” rating on shares of Cello Group plc in a research report on Wednesday, September 14th. Peel Hunt reaffirmed a “buy” rating on shares of Cello Group plc in a research report on Wednesday, July 13th. Finally, Cenkos Securities Ltd reaffirmed a “buy” rating on shares of Cello Group plc in a research report on Wednesday, September 14th. Five investment analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus target price of GBX 123.75 ($1.62).
Shares of Cello Group plc (LON:CLL) opened at 106.50 on Tuesday. Cello Group plc has a 52-week low of GBX 77.10 and a 52-week high of GBX 115.00. The stock’s 50 day moving average is GBX 105.65 and its 200 day moving average is GBX 98.83. The stock’s market capitalization is GBX 92.45 million.
The firm also recently disclosed a dividend, which will be paid on Friday, November 4th. Stockholders of record on Thursday, October 6th will be given a GBX 1 ($0.01) dividend. This represents a dividend yield of 0.94%. The ex-dividend date is Thursday, October 6th.
About Cello Group plc
Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company’s pharmaceutical and healthcare clients.
Receive News & Stock Ratings for Cello Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cello Group plc and related stocks with our FREE daily email newsletter.